Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

New policy for a proven experience of medical technology by the MTP Council in Sweden

25 Nov 2022

In November 2022, Swedish Medical Technologies Product (MTP) Council issued a policy of proven experience for medical technology. MTP Council defines proven experience as the profession's assessment, based on experience, of how appropriate medical technology is in specific conditions. The profession includes all professional groups that treat or otherwise have insight into the patient's condition.

Experience can be proven in different ways. The policy provides some examples of how the MTP Council acquires knowledge of proven experience, including input from horizon scanning, individual regions, the Dental and Medicines Agency's (TLV), and the National Program Areas (NPOs).

In cases where scientific evidence shows an effect, but the proven experience is lacking or shows doubt about a product's usefulness, the MTP Council would recommend a phased introduction where the product is tested in consultation with one or more regions with structured follow-up.

In cases where there is a lack of sufficient scientific evidence, but there is proven experience of effect, the MTP Council would recommend using the product within the context of research.

See more information in Swedish here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).